Resoconti Innate Pharma

Azioni

Mercato chiuso - Euronext Paris Altri mercati azionari 17:35:03 08/05/2024			Variaz. 5gg	Var. 1 gen.
2,29 ^EUR	0,00%		+3,85%	-12,60%

15/04	Innate Pharma annuncia l'avanzamento dell'attivatore delle cellule NK SAR443579 / IPH6101, sviluppato da Sanofi, alla Fase 2 per i pazienti affetti da cancro del sangue.	CI
10/04	Innate Pharma S.A. presenta all'AACR 2024 l'efficacia preclinica del suo candidato farmaco preindustriale IPH45, un nuovo coniugato anticorpo-droga con la Nectina-4	CI

Transcript : Innate Pharma S.A., 2023 Earnings Call, Mar 21, 2024	21/03
Transcript : Innate Pharma S.A. - Special Call	12/12
Transcript : Innate Pharma S.A., Q3 2023 Earnings Call, Nov 14, 2023	14/11
Transcript : Innate Pharma S.A., H1 2023 Earnings Call, Sep 14, 2023	14/09/23
Transcript : Innate Pharma S.A., Q1 2023 Earnings Call, May 10, 2023	10/05/23
Transcript : Innate Pharma S.A., 2022 Earnings Call, Mar 23, 2023	23/03/23
Transcript : Innate Pharma S.A., Q3 2022 Earnings Call, Nov 14, 2022	14/11/22
Transcript : Innate Pharma S.A., H1 2022 Earnings Call, Sep 15, 2022	15/09/22
Transcript : Innate Pharma S.A., Q1 2022 Earnings Call, May 10, 2022	10/05/22
Transcript : Innate Pharma S.A., 2021 Earnings Call, Mar 24, 2022	24/03/22
Transcript : Innate Pharma S.A., Q3 2021 Earnings Call, Nov 16, 2021	16/11/21
Transcript : Innate Pharma S.A., H1 2021 Earnings Call, Sep 15, 2021	15/09/21
Transcript : Innate Pharma S.A. - Special Call	23/06/21
Transcript : Innate Pharma S.A., Q1 2021 Earnings Call, May 11, 2021	11/05/21
Transcript : Innate Pharma S.A., 2020 Earnings Call, Mar 18, 2021	18/03/21
Transcript : Innate Pharma S.A. - Special Call	09/02/21
Transcript : Innate Pharma S.A. - Special Call	11/12/20
Transcript : Innate Pharma S.A., H1 2020 Earnings Call, Sep 08, 2020	08/09/20
Transcript : Innate Pharma S.A. - Special Call	24/06/20
Transcript : Innate Pharma S.A., 2019 Earnings Call, Mar 10, 2020	10/03/20

Non ci sono risultati per questa ricerca